|
Irie, Reiko F; Ollila, David W; O'Day, Steven et al. (2004) Phase I pilot clinical trial of human IgM monoclonal antibody to ganglioside GM3 in patients with metastatic melanoma. Cancer Immunol Immunother 53:110-7
|
|
Takahashi, T; Johnson, T D; Nishinaka, Y et al. (1999) IgM anti-ganglioside antibodies induced by melanoma cell vaccine correlate with survival of melanoma patients. J Invest Dermatol 112:205-9
|
|
Nishinaka, Y; Hoon, D S; Irie, R F (1998) Human IgM antibodies to tumor-associated gangliosides share VHIII (V3-23) and VKIV family subgroups. Immunogenetics 48:73-5
|
|
Takahashi, T; Conforti, A; Kikumoto, Y et al. (1998) Augmentation of IgM antibody to gp43 tumor-associated antigen peptide by melanoma cell vaccine. J Clin Immunol 18:299-305
|
|
Zhang, Z; Irie, R F; Chi, D D et al. (1998) Cellular immuno-PCR. Detection of a carbohydrate tumor marker. Am J Pathol 152:1427-32
|
|
Takahashi, T; Irie, R F; Morton, D L et al. (1997) Recognition of gp43 tumor-associated antigen peptide by both HLA-A2 restricted CTL lines and antibodies from melanoma patients. Cell Immunol 178:162-71
|
|
Nishinaka, Y; Ravindranath, M H; Irie, R F (1996) Development of a human monoclonal antibody to ganglioside G(M2) with potential for cancer treatment. Cancer Res 56:5666-71
|
|
Kikumoto, Y; Oka, T; Cao, J N et al. (1995) Peptides with carboxyl-terminal sequence of alanine-proline: detection by a human monoclonal antibody. Hybridoma 14:45-50
|
|
Morioka, N; Kikumoto, Y; Hoon, D S et al. (1995) Cytotoxic T cell recognition of a human melanoma derived peptide with a carboxyl-terminal alanine-proline sequence. Mol Immunol 32:573-81
|
|
Oka, T; Kikumoto, Y; Itakura, K et al. (1994) Human monoclonal antibody identified an immunoreactive tetrapeptide sequence (Lys-Tyr-Gln-Ile) in M(r) 43,000 protein of human melanoma. Cancer Res 54:3511-5
|
Showing the most recent 10 out of 26 publications
